An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Recap by typeshit. Full story at HDFC Sky.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
CX11, a daily oral pill, showed up to 11.5% weight loss at 36 weeks in phase 2. The money is meant to carry it through global phase 3.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The Times looks at current options for the facial volume loss that can come with rapid GLP-1 weight loss. Full details are on the site.
Loading…